Advanced search
Publication Cover
Leukemia & Lymphoma Volume 65, 2024 - Issue 6
Submit an article Journal homepage
146
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP

Ronald Nemeca Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USAView further author information
,
Marielle Scherrer-Crosbieb Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USAView further author information
,
Jeremy S. Abramsona Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USAView further author information
,
Robert Reddc Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USAView further author information
,
Hannah K. Gilmand Division of Cardiology, Massachusetts General Hospital, Boston, MA, USAView further author information
,
Terry Hod Division of Cardiology, Massachusetts General Hospital, Boston, MA, USAView further author information
,
Jessica Wud Division of Cardiology, Massachusetts General Hospital, Boston, MA, USAView further author information
,
Julius Heemelaard Division of Cardiology, Massachusetts General Hospital, Boston, MA, USAView further author information
,
Donna Neubergc Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USAView further author information
,
Ephraim P. Hochberga Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USAView further author information
,
Jeffrey A. Barnesa Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USAView further author information
,
Philippe Armande Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information
,
Eric D. Jacobsene Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information
,
Caron A. Jacobsone Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information
,
Austin I. Kime Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information
,
Robb S. Friedmanf Division of Medical Oncology, Newton-Wellesley Hospital, Newton, MA, USAView further author information
,
Ann S. LaCascee Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information
,
Tomas G. Neiland Division of Cardiology, Massachusetts General Hospital, Boston, MA, USAView further author information
&
Jacob D. Soumeraia Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3062-6819View further author information
ORCID Icon show all
Pages 783-788 | Received 18 Oct 2023, Accepted 06 Feb 2024, Published online: 21 Feb 2024

References

  • Tilly H, Morschhauser F, Sehn LH, et al. Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med. 2022;386(4):351–363. doi:10.1056/NEJMoa2115304
  • Pfreundschuh M, Trümper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol. 2006;7(5):379–391. doi:10.1016/S1470-2045(06)70664-7
  • Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d‘Etude des Lymphomes de l‘Adulte. J Clin Oncol. 2005;23(18):4117–4126. doi:10.1200/JCO.2005.09.131
  • Neilan TG, Quinaglia T, Onoue T, et al. Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial. JAMA. 2023;330(6):528–536. doi:10.1001/jama.2023.11887
  • Gouni S, Strati P, Toruner G, et al. Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma. Leuk Lymphoma. 2022;63(6):1302–1313. doi:10.1080/10428194.2021.2020782
  • Increased rituximab (R) doses eliminate increased risk and improve outcome of elderly male patients with aggressive CD20+ B-cell lymphomas: the SEXIE-R-CHOP-14 trial of the DSHNHL. Clin Adv Hematol Oncol. 2014;12(8 Suppl. 16):8–9.
  • Atorvastatin [package insert]. New York (NY): Pfizer Pharmaceuticals; 2019.
  • Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–282. doi:10.1182/blood-2003-05-1545
  • Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–3068. doi:10.1200/JCO.2013.54.8800
  • R: a language and environment for statistical computing. R Foundation for Statistical Computing; 2022. Available from: https://www.R-project.org/
  • Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clin Cancer Res. 2003;9(1):10–19.
  • Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med. 2008;14(1):37–44. doi:10.1016/j.molmed.2007.11.004
  • Fritz G. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). Int J Oncol. 2005;27(5):1401–1409. doi:10.3892/ijo.27.5.1401
  • Gauthaman K, Fong CY, Bongso A. Statins, stem cells, and cancer. J Cell Biochem. 2009;106(6):975–983. doi:10.1002/jcb.22092
  • Jakobisiak M, Golab J. Potential antitumor effects of statins (review). Int J Oncol. 2003;23(4):1055–1069.
  • Wong WW, Dimitroulakos J, Minden MD, et al. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia. 2002;16(4):508–519. doi:10.1038/sj.leu.2402476

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.